Your session is about to expire
← Back to Search
Behavioral Intervention
SmokefreeSGM Español for Smoking Cessation
N/A
Waitlist Available
Led By Irene Tami-Maury, DMD, MSc, DrPH
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Have smoked at least 100 cigarettes in their lifetime, smoke every day, and smoke ≥ 5 cigarettes a day
Be older than 18 years old
Must not have
Have a cell phone number that does not work and/or is registered to someone else
Current use of tobacco products other than cigarettes or electronic nicotine delivery systems (ENDS) (i.e., cigar, cigarillo, little cigar, pipe, Hookah)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up end of intervention (1month after quit date)
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to see how well the SmokefreeSGM Español program, designed specifically for Spanish-speaking smokers who are part of the SGM community, is received and used.
Who is the study for?
This trial is for Spanish-speaking individuals who identify as part of the sexual and gender minority (SGM) community and are interested in quitting smoking. Specific eligibility criteria have not been provided.
What is being tested?
The study is testing SmokefreeSGM Español, a text-based program designed to help SGM individuals who prefer Spanish to quit smoking. It aims to evaluate how user-friendly, engaging, and acceptable the intervention is.
What are the potential side effects?
Since this intervention involves a text-based smoking cessation program, there are no direct medical side effects associated with it. However, participants may experience typical nicotine withdrawal symptoms.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I smoke 5 or more cigarettes daily and have smoked at least 100 in my life.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
My cell phone number is either inactive or registered to another person.
Select...
I currently use tobacco products that are not cigarettes or e-cigarettes.
Select...
I lack the necessary equipment for telehealth and cannot meet in person.
Select...
I am currently using medication to help me stop smoking.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ end of intervention (1month after quit date)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~end of intervention (1month after quit date)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Acceptability at 1 month as Assessed by the System Usability Scale (SUS)
Perceived Usability as Assessed by the System Usability Scale (SUS)
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Beta testing groupExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
SmokefreeSGM
2022
N/A
~120
Find a Location
Who is running the clinical trial?
The University of Texas Health Science Center, HoustonLead Sponsor
957 Previous Clinical Trials
347,837 Total Patients Enrolled
Irene Tami-Maury, DMD, MSc, DrPHPrincipal InvestigatorThe University of Texas Health Science Center, Houston
1 Previous Clinical Trials
18 Total Patients Enrolled